Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

BACKGROUND: Squamous cell carcinoma (SCC) is one of the most common subtypes of non-small cell lung cancer, but its treatment options remain limited. Epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors (TKIs) have limited efficacy in the treatment of lung SCC. Here, we report an SCC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhiqin, Lin, Jiamao, Yang, Linke, Li, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539605/
https://www.ncbi.nlm.nih.gov/pubmed/37781197
http://dx.doi.org/10.3389/fonc.2023.1188772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539605/
https://www.ncbi.nlm.nih.gov/pubmed/37781197
http://dx.doi.org/10.3389/fonc.2023.1188772

Ejemplares similares